Latest News
8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine
As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.
Today's Top Reads
Close
-
Did you like reading this story? Click the heart to show your love.
213 -
Did you like reading this story? Click the heart to show your love.
67 -
Did you like reading this story? Click on the heart to show your love.
67
Did you like reading this story? Click the heart to show your love.
1140
Learn about the innovative ways the company is mobilizing to help combat the global outbreak caused by the novel coronavirus.
More from Johnson & Johnson
July 21, 2021
Check out this infographic breakdown of the company’s second-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Device businesses.
July 19, 2021
A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.
June 29, 2021
For more than a century, Johnson & Johnson has used a core set of values to help build its business. Now, that sense of purpose has landed it on the Fortune ROL100, a new ranking of corporate leadership.
